carbidopa

Generic: carbidopa tablets

Labeler: oceanside pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name carbidopa
Generic Name carbidopa tablets
Labeler oceanside pharmaceuticals
Dosage Form TABLET
Routes
ORAL
Active Ingredients

carbidopa 25 mg/1

Manufacturer
Oceanside Pharmaceuticals

Identifiers & Regulatory

Product NDC 68682-200
Product ID 68682-200_ccf10efe-4fda-40a4-8f20-1ccefb151a15
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA017830
Listing Expiration 2026-12-31
Marketing Start 2014-04-04

Pharmacologic Class

Established (EPC)
aromatic amino acid decarboxylation inhibitor [epc]
Mechanism of Action
dopa decarboxylase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68682200
Hyphenated Format 68682-200

Supplemental Identifiers

RxCUI
260260
UNII
MNX7R8C5VO
NUI
N0000175754 N0000175755

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name carbidopa (source: ndc)
Generic Name carbidopa tablets (source: ndc)
Application Number NDA017830 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (68682-200-25)
source: ndc

Packages (1)

68682-200-25 100 TABLET in 1 BOTTLE (68682-200-25)

Ingredients (1)

carbidopa (25 mg/1)

Linked Drug Pages (1)

Carbidopa ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ccf10efe-4fda-40a4-8f20-1ccefb151a15", "openfda": {"nui": ["N0000175754", "N0000175755"], "unii": ["MNX7R8C5VO"], "rxcui": ["260260"], "spl_set_id": ["d5204e5e-10ef-4758-8fc6-cb710048c687"], "pharm_class_epc": ["Aromatic Amino Acid Decarboxylation Inhibitor [EPC]"], "pharm_class_moa": ["DOPA Decarboxylase Inhibitors [MoA]"], "manufacturer_name": ["Oceanside Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68682-200-25)", "package_ndc": "68682-200-25", "marketing_start_date": "20140404"}], "brand_name": "Carbidopa", "product_id": "68682-200_ccf10efe-4fda-40a4-8f20-1ccefb151a15", "dosage_form": "TABLET", "product_ndc": "68682-200", "generic_name": "Carbidopa Tablets", "labeler_name": "Oceanside Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbidopa", "active_ingredients": [{"name": "CARBIDOPA", "strength": "25 mg/1"}], "application_number": "NDA017830", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20140404", "listing_expiration_date": "20261231"}